Inflammation and aging-related disease: A transdisciplinary inflammaging framework
- PMID: 39352664
- PMCID: PMC11872841
- DOI: 10.1007/s11357-024-01364-0
Inflammation and aging-related disease: A transdisciplinary inflammaging framework
Abstract
Inflammaging, a state of chronic, progressive low-grade inflammation during aging, is associated with several adverse clinical outcomes, including frailty, disability, and death. Chronic inflammation is a hallmark of aging and is linked to the pathogenesis of many aging-related diseases. Anti-inflammatory therapies are also increasingly being studied as potential anti-aging treatments, and clinical trials have shown benefits in selected aging-related diseases. Despite promising advances, significant gaps remain in defining, measuring, treating, and integrating inflammaging into clinical geroscience research. The Clin-STAR Inflammation Research Interest Group was formed by a group of transdisciplinary clinician-scientists with the goal of advancing inflammaging-related clinical research and improving patient-centered care for older adults. Here, we integrate insights from nine medical subspecialties to illustrate the widespread impact of inflammaging on diseases linked to aging, highlighting the extensive opportunities for targeted interventions. We then propose a transdisciplinary approach to enhance understanding and treatment of inflammaging that aims to improve comprehensive care for our aging patients.
Keywords: Aging-related diseases; Cellular senescence; Geriatrics; Inflammaging; Internal medicine.
© 2024. The Author(s), under exclusive licence to American Aging Association.
Conflict of interest statement
Declarations. Competing interests: Sebastian E. Sattui: research funding from AstraZeneca and GlaxoSmithKline (clinical trials), consulting and advisory boards for Sanofi and Amgen (funds applied for research support), and speaker fees from Fresenius Kabi (funds applied for research support). Bharati Kochar: advisory boards for Pfizer, Inc. and Bristol Meyers Squibb. Adam S. Faye: consulting honoraria from Bristol Meyers Squibb, Abbvie, and Takeda. Michael J. Devinney: research funding from Merck Sharp & Dohme LLC (clinical trials). Sara C. LaHue: speaker honoraria from American Academy of Neurology and Medscape.
Figures
References
-
- Franceschi C, Valensin S, Bonafè M, Paolisso G, Yashin AI, Monti D, De Benedictis G. The network and the remodeling theories of aging: historical background and new perspectives. Exp Gerontol. 2000;35:879–96. 10.1016/S0531-5565(00)00172-8. - PubMed
-
- Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908:244–54. 10.1111/j.1749-6632.2000.tb06651.x. - PubMed
-
- Müller-Werdan U, Nuding S, Ost M. Assessing inflammageing. Curr Opin Clin Nutr Metab Care. 2017;20:346–8. 10.1097/MCO.0000000000000391. - PubMed
-
- Suryadevara V, Hudgins AD, Rajesh A, Pappalardo A, Karpova A, Dey AK, Hertzel A, Agudelo A, Rocha A, Soygur B, Schilling B, Carver CM, Aguayo-Mazzucato C, Baker DJ, Bernlohr DA, Jurk D, Mangarova DB, Quardokus EM, Enninga EAL, Schmidt EL, Chen F, Duncan FE, Cambuli F, Kaur G, Kuchel GA, Lee G, Daldrup-Link HE, Martini H, Phatnani H, Al-Naggar IM, Rahman I, Nie J, Passos JF, Silverstein JC, Campisi J, Wang J, Iwasaki K, Barbosa K, Metis K, Nernekli K, Niedernhofer LJ, Ding L, Wang L, Adams LC, Ruiyang L, Doolittle ML, Teneche MG, Schafer MJ, Xu M, Hajipour M, Boroumand M, Basisty N, Sloan N, Slavov N, Kuksenko O, Robson P, Gomez PT, Vasilikos P, Adams PD, Carapeto P, Zhu Q, Ramasamy R, Perez-Lorenzo R, Fan R, Dong R, Montgomery RR, Shaikh S, Vickovic S, Yin S, Kang S, Suvakov S, Khosla S, Garovic VD, Menon V, Xu Y, Song Y, Suh Y, Dou Z, Neretti N. SenNet recommendations for detecting senescent cells in different tissues. Nat Rev Mol Cell Biol. 2024. 10.1038/s41580-024-00738-8. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- R03AG067976/AG/NIA NIH HHS/United States
- K23 AG080066/AG/NIA NIH HHS/United States
- K76 AG083285/AG/NIA NIH HHS/United States
- U24AG065204/AG/NIA NIH HHS/United States
- K23AG082727/AG/NIA NIH HHS/United States
- R03AG067949/AG/NIA NIH HHS/United States
- R03AG078953/AG/NIA NIH HHS/United States
- K08HL159353/HL/NHLBI NIH HHS/United States
- R03 AG074056/AG/NIA NIH HHS/United States
- R03AG074056/AG/NIA NIH HHS/United States
- KL2 TR001870/TR/NCATS NIH HHS/United States
- R03 AG078953/AG/NIA NIH HHS/United States
- K08 HL159353/HL/NHLBI NIH HHS/United States
- R03AG078927/AG/NIA NIH HHS/United States
- K76 AG083286/AG/NIA NIH HHS/United States
- R03AG067981/AG/NIA NIH HHS/United States
- R03AG082857/AG/NIA NIH HHS/United States
- R03AG074059/AG/NIA NIH HHS/United States
- R03AG078946/AG/NIA NIH HHS/United States
- R03 AG078946/AG/NIA NIH HHS/United States
- K08AG061144/AG/NIA NIH HHS/United States
- 23AACSF-1029536/ALZ/Alzheimer's Association/United States
- R03AG074035/AG/NIA NIH HHS/United States
- K23AR079588/AG/NIA NIH HHS/United States
- KL2TR001870/National Center for Advancing Translational Sciences/National Institutes of Health
- K23 DK129774/DK/NIDDK NIH HHS/United States
- Robert A. Winn Diversity in Clinical Trials Career Development Award/Bristol Myers Squibb Foundation
- K76AG083309/AG/NIA NIH HHS/United States
- P30AG0287163/AG/NIA NIH HHS/United States
- K23 AG082727/AG/NIA NIH HHS/United States
- R03 AG074035/AG/NIA NIH HHS/United States
- R03 AG078927/AG/NIA NIH HHS/United States
- U24 AG065204/AG/NIA NIH HHS/United States
- K23DK129774/DK/NIDDK NIH HHS/United States
- L30 GM125129/GM/NIGMS NIH HHS/United States
- P30 AG044281/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical